A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders - PubMed (original) (raw)

A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders

Jonas F Ludvigsson et al. JAMA Psychiatry. 2013 Nov.

Abstract

Importance: Most case reports suggest an association between autistic spectrum disorders (ASDs) and celiac disease (CD) or positive CD serologic test results, but larger studies are contradictory.

Objective: To examine the association between ASDs and CD according to small intestinal histopathologic findings.

Design and setting: Nationwide case-control study in Sweden.

Main outcomes and measures: Through 28 Swedish biopsy registers, we collected data about 26,995 individuals with CD (equal to villous atrophy, Marsh stage 3), 12,304 individuals with inflammation (Marsh stages 1-2), and 3719 individuals with normal mucosa (Marsh stage 0) but positive CD serologic test results (IgA/IgG gliadin, endomysium, or tissue transglutaminase) and compared them with 213,208 age- and sex-matched controls. Conditional logistic regression estimated odds ratios (ORs) for having a prior diagnosis of an ASD according to the Swedish National Patient Register. In another analysis, we used the Cox proportional hazards regression model to estimate hazard ratios (HRs) for future ASDs in individuals undergoing small intestinal biopsy.

Results: A prior ASD was not associated with CD (OR, 0.93; 95% CI, 0.51-1.68) or inflammation (OR 1.03; 95% CI, 0.40-2.64) but was associated with a markedly increased risk of having a normal mucosa but a positive CD serologic test result (OR, 4.57; 95% CI, 1.58-13.22). Restricting our data to individuals without a diagnosis of an ASD at the time of biopsy, CD (HR, 1.39; 95% CI, 1.13-1.71) and inflammation (HR, 2.01; 95% CI, 1.29-3.13) were both associated with moderate excess risks of later ASDs, whereas the HR for later ASDs in individuals with normal mucosa but positive CD serologic test results was 3.09 (95% CI, 1.99-4.80).

Conclusions and relevance: Although this study found no association between CD or inflammation and earlier ASDs, there was a markedly increased risk of ASDs in individuals with normal mucosa but a positive CD serologic test result.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

(The other authors have no conflict of interest to declare).

Figures

Figure 1

Figure 1. Flowchart of study participants

CD, Coeliac disease * Marsh pathology grade 1–2. # Marsh pathology grade 0 in individuals with positive CD serology (antigliadin, antiendomysial or anti-transglutaminase antibodies).

References

    1. Wing L, Yeates SR, Brierley LM, Gould J. The prevalence of early childhood autism: comparison of administrative and epidemiological studies. Psychol Med. 1976 Feb;6(1):89–100. -PubMed
    1. Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012 Mar 30;61(3):1–19. -PubMed
    1. Emond A, Emmett P, Steer C, Golding J. Feeding symptoms, dietary patterns, and growth in young children with autism spectrum disorders. Pediatrics. 2010 Aug;126(2):e337–e342. -PubMed
    1. Geschwind DH. Advances in autism. Annu Rev Med. 2009;60:367–380. -PMC -PubMed
    1. Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarsater H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry. 2010 Nov;167(11):1357–1363. -PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources